Unknown

Dataset Information

0

Antifungal activity of naphthoquinoidal compounds in vitro against fluconazole-resistant strains of different Candida species: a special emphasis on mechanisms of action on Candida tropicalis.


ABSTRACT: In recent decades, the incidence of candidemia in tertiary hospitals worldwide has substantially increased. These infections are a major cause of morbidity and mortality; in addition, they prolong hospital stays and raise the costs associated with treatment. Studies have reported a significant increase in infections by non-albicans Candida species, especially C. tropicalis. The number of antifungal drugs on the market is small in comparison to the number of antibacterial agents available. The limited number of treatment options, coupled with the increasing frequency of cross-resistance, makes it necessary to develop new therapeutic strategies. The objective of this study was to evaluate and compare the antifungal activities of three semisynthetic naphthofuranquinone molecules against fluconazole-resistant Candida spp. strains. These results allowed to us to evaluate the antifungal effects of three naphthofuranquinones on fluconazole-resistant C. tropicalis. The toxicity of these compounds was manifested as increased intracellular ROS, which resulted in membrane damage and changes in cell size/granularity, mitochondrial membrane depolarization, and DNA damage (including oxidation and strand breakage). In conclusion, the tested naphthofuranquinones (compounds 1-3) exhibited in vitro cytotoxicity against fluconazole-resistant Candida spp. strains.

SUBMITTER: Neto JB 

PROVIDER: S-EPMC4015898 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications


In recent decades, the incidence of candidemia in tertiary hospitals worldwide has substantially increased. These infections are a major cause of morbidity and mortality; in addition, they prolong hospital stays and raise the costs associated with treatment. Studies have reported a significant increase in infections by non-albicans Candida species, especially C. tropicalis. The number of antifungal drugs on the market is small in comparison to the number of antibacterial agents available. The li  ...[more]

Similar Datasets

| S-EPMC9377531 | biostudies-literature
| S-EPMC10795414 | biostudies-literature
| S-EPMC8929679 | biostudies-literature
| S-EPMC5487674 | biostudies-literature
| S-EPMC5681995 | biostudies-literature
| S-EPMC4879420 | biostudies-literature
| S-EPMC9505055 | biostudies-literature
| S-EPMC8714089 | biostudies-literature
| S-EPMC89916 | biostudies-literature
| S-EPMC6595430 | biostudies-literature